Results 221 to 230 of about 111,339,475 (290)

32. The Value of the Independent Program Training Pathway

open access: yesPlastic and Reconstructive Surgery, Global Open
Ariel E. Figueroa, MD   +4 more
doaj   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

22. Enhancing The Accuracy Of Planned Surgery With Computer Controlled Osteotomies

open access: yesPlastic and Reconstructive Surgery, Global Open
Naji Bou Zeid, MD   +7 more
doaj   +1 more source

Age- and Genotype-Associated Specific Expression of IL-1 and TNF Receptors on Immunocompetent Cells. [PDF]

open access: yesInt J Mol Sci
Zhukova J   +5 more
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

SO27. First Rib-Sparing Vs. Rib Resection in Thoracic Outlet Syndrome: Functional Outcomes in 105 Patients

open access: yesPlastic and Reconstructive Surgery, Global Open
Iulianna Taritsa, BA   +10 more
doaj   +1 more source

Early IL-1 Inhibition in Still's Disease: A Window of Opportunity for Improving Outcomes. [PDF]

open access: yesACR Open Rheumatol
Bindoli S   +5 more
europepmc   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

SP08. Uncovering the Socioeconomic Determinants of Breast Reconstruction Outcomes Across Diverse Demographics

open access: yesPlastic and Reconstructive Surgery, Global Open
Bradley A. Melnick, BS   +6 more
doaj   +1 more source

TAFRO syndrome requiring combined IL 6 and IL 1 inhibition: a case report. [PDF]

open access: yesFront Immunol
Sultan AW   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy